The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 14, 2020
Filed:
Nov. 29, 2013
Applicant:
Nestec S.a., Vevey, CH;
Inventors:
Lucas Actis Goretta, Lausanne, CH;
Marcia Da Silva Pinto, Lausanne, CH;
Maria Belen Sanchez Bridge, Penthaz, CH;
Emmanuelle Bertschy, Vich, CH;
Antoine Leveques, Epalinges, CH;
Assignee:
Societe des Produits Nestle S.A., Vevey, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/353 (2006.01); A61Q 19/00 (2006.01); A23L 33/125 (2016.01); A23L 5/00 (2016.01); A23L 2/52 (2006.01); A61K 8/97 (2017.01); A61K 8/60 (2006.01); A61K 8/49 (2006.01); A23L 2/60 (2006.01); A23K 20/163 (2016.01); A23L 29/30 (2016.01); A23L 33/105 (2016.01); A23L 33/10 (2016.01); A23K 20/111 (2016.01); A23L 7/00 (2016.01);
U.S. Cl.
CPC ...
A23L 33/125 (2016.08); A23K 20/111 (2016.05); A23K 20/163 (2016.05); A23L 2/52 (2013.01); A23L 2/60 (2013.01); A23L 5/00 (2016.08); A23L 29/30 (2016.08); A23L 33/10 (2016.08); A23L 33/105 (2016.08); A61K 8/498 (2013.01); A61K 8/60 (2013.01); A61K 8/97 (2013.01); A61K 31/353 (2013.01); A61Q 19/00 (2013.01); A23L 7/00 (2016.08); A23V 2002/00 (2013.01); A61K 2800/10 (2013.01); A61K 2800/92 (2013.01);
Abstract
The present invention relates generally to the field of flavan-3-ols. In particular, the present invention provides a way to increase the bioavailability of flavan-3-ols. Embodiments of the present invention relate to the use of at least one carbohydrate with a glycemic index of less than 50 in a composition comprising at least one flavan-3-ol for increasing the bioavailability of said flavan-3-ol.